Evidence map›Paper›PMID 26563254›Full record

ReviewScandinavian journal of public health2016

Measles among migrants in the European Union and the European Economic Area.

Gemma A Williams, Sabrina Bacci, Rebecca Shadwick, Taavi Tillmann, Bernd Rechel, Teymur Noori, Jonathan E Suk, Anna Odone, Jonathan D Ingleby, Philipa Mladovsky and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Scandinavian journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Infectious Diseases among Refugee Children.Children (Basel, Switzerland) · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Gemma A WilliamsLSE Health, London School of Economics and Political Science (LSE), London, UK g.a.williams@lse.ac.uk.
Sabrina BacciEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Rebecca ShadwickLSE Health, London School of Economics and Political Science (LSE), London, UK.
Taavi TillmannECOHOST, London School of Hygiene and Tropical Medicine, London, UK.
Bernd RechelEuropean Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, London, UK.
Teymur NooriEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Jonathan E SukEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Anna OdoneEuropean Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, London, UK Department of Global Health and Social Medicine, Harvard School of Public Health, Harvard University, Boston, MA, USA.
Jonathan D InglebySchool of Medicine, University of Parma, Parma, Italy.
Philipa MladovskyLSE Health, London School of Economics and Political Science (LSE), London, UK.
Martin MckeeEuropean Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, London, UK.
European Centre for Disease Prevention and Control · SELondon School of Economics and Political Science · GBLondon School of Hygiene & Tropical Medicine · GBHarvard Global Health Institute · USUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsProgress towards meeting the goal of measles elimination in the EU and the European Economic Area (EEA) by 2015 is being obstructed, as some children are either not immunized on time or never immunized. One group thought to be at increased risk of measles is migrants; however, the extent to which this is the case is poorly understood, due to a lack of data. This paper addresses this evidence gap by providing an overview of the burden of measles in migrant populations in the EU/EEA.

methodsData were collected through a comprehensive literature review, a country survey of EU/EEA member states and information from measles experts gathered at an infectious disease workshop.

resultsOur results showed incomplete data on measles in migrant populations, as national surveillance systems do not systematically record migration-specific information; however, evidence from the literature review and country survey suggested that some measles outbreaks in the EU/EEA were due to sub-optimal vaccination coverage in migrant populations.

conclusionsWe conclude that it is essential that routine surveillance of measles cases and measles, mumps and rubella (MMR) vaccination coverage become strengthened, to capture migrant-specific data. These data can help to inform the provision of preventive services, which may need to reach out to vulnerable migrant populations that currently face barriers in accessing routine immunization and health services.

Indexed as

Population SurveillanceChildDisease EradicationEuropeEuropean UnionGoalsHumansMeaslesMeasles-Mumps-Rubella VaccineTransients and MigrantsMeasles-Mumps-Rubella VaccineEpidemiologyEuropeEuropean Economic Areaimmunizationmeaslesmigrant healthmigrantspreventive servicessurveillancevaccination

Identifiers

PMID26563254
PMCPMC4741262
OpenAlexW2229349867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.